Resource utilization and preparedness within the COVID-19 pandemic in Tunisian medical intensive care units: A nationwide retrospective multicentre observational study

Boussarsar, Mohamed; Meddeb, Khaoula; Toumi, Radhouane; Ennouri, Emna; Ayed, Samia; Jarraya, Fatma; Khelil, Jalila Ben; Jaoued, Oussama; Nouira, H.; Atrous, Souheil El; Essafi, Fatma; Talik, Imen; Merhabane, Takoua; Trifi, Ahlem; Seghir, Eya; Abdellatif, Sami; Doghri, Hamdi; Bahri, Badra; Borsali, Nebiha; Fathallah, Ines; Ksouri, Meriam; Kouraichi, Nadia; Jazia, Amira Ben; Ghezala, Hassan Ben; Brahmi, Nozha

doi:10.1016/j.jiph.2023.02.022

Cited by 7 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic, caused by SARS-CoV-2, has had a profound impact on global public health, resulting in more than 6.9 million deaths worldwide by April 2023 ( 48 ). This pandemic has severely tested the resilience of healthcare systems in low- and middle-income countries, where resources were already limited prior to the outbreak ( 49 , 50 ). Furthermore, numerous cases of coinfections with respiratory viruses, bacteria, and fungi have been reported in patients infected with SARS-CoV-2 ( 51 , 52 ).…”

Section: Discussionmentioning

confidence: 99%

Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador

Morales-Jadán,

Muslin,

Viteri-Dávila

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

Worldwide, the COVID-19 pandemic caused by SARS-CoV-2 has enormously impacted healthcare systems, especially in low and middle-income countries. Coinfections with respiratory pathogens in COVID-19 patients may contribute to worse outcomes. This study identified the presence of 12 viral coinfections and pneumococcal carriers among individuals with SARS-CoV-2 infection in outpatient and community settings in Ecuador. From January 2020 to November 2021, 215 nasopharyngeal and nasal swabs were taken from individuals who reported symptoms of COVID-19 or had known exposure to someone with confirmed or suspected COVID-19. One hundred fifty-eight tested positive for SARS-CoV-2 by RT-qPCR and coinfections were detected in 12% (19/158) of SARS-CoV-2-positive patients; the most frequent coinfection was with influenza A virus at 4.4% (7/158; 95% CI: 1.2–7.6), followed by respiratory syncytial virus with 3.1% (5/158; 95% CI: 0.4–5.8), and finally rhinovirus and human coronavirus NL63 with 1.2% (2/158). Pneumococcal carriage was detected in 3.7% (6/158; 95% CI: 0.76–6.64) of SARS-CoV-2 cases. Influenza B, adenovirus, human metapneumovirus (HMPV), parainfluenza virus types 1, 2, and 3, and human coronavirus HKU1 were undetected. To our knowledge, this is the first study of coinfection of SARS-CoV-2 and respiratory pathogens performed on outpatients in Latin America. The high proportion of outpatients with viral coinfections reported in our cohort allows us to suggest that testing for SARS-CoV-2 and other common respiratory pathogens should be carried out to ensure accurate diagnoses, prompt patient treatment, and appropriate isolation.

show abstract

Section: Discussionmentioning

confidence: 99%

Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador

Morales-Jadán,

Muslin,

Viteri-Dávila

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

Laboratory testing efficiency during the COVID pandemic: Findings from the Primary Health Care Corporation laboratories in the State of Qatar

Awwad,

Al-Hamdani,

Abdallah

et al. 2024

Journal of Infection and Public Health

View full text Add to dashboard Cite

The facilitators and barriers to implementing virtual visits in intensive care units: A mixed‐methods systematic review

Li,

Shi,

Chen

et al. 2024

Evaluation Clinical Practice

View full text Add to dashboard Cite

BackgroundVisitation has a positive effect on patients and families, yet, it can disrupt intensive care unit (ICU) care and increase the risk of patient infections, which previously favoured face‐to‐face visits. The coronavirus disease 2019 (COVID‐19) pandemic has raised the importance of virtual visits and led to their widespread adoption globally, there are still many implementation barriers that need to be improved. Therefore, this review aimed to explore the use of ICU virtual visit technology during the COVID‐19 pandemic and the barriers and facilitators of virtual visits to improve virtual visits in ICUs.MethodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, six databases (CINAHL, China National Knowledge Infrastructure [CNKI], PubMed, Cochrane, VIP and Wang Fang databases) were searched for empirical studies published between 1 January 2020 and 22 October 2023. Studies that investigated and reported barriers to and facilitators of implementing virtual visits in ICUs during the COVID‐19 pandemic were included. Evidence from the included studies was identified and thematically analysed using Thomas and Harden's three‐step approach. Study quality was appraised with the Mixed‐Methods Appraisal Tool.ResultsA total of 6770 references were screened, of which 35 studies met the inclusion criteria after a full‐text review. Eight main barriers to virtual visits use were identified: technical difficulties; insufficient resources; lack of physical presence and nonverbal information; low technical literacy; differences in families' perceptions of visual cues; privacy and ethics issues; inequitable access and use of virtual visit technology; and lack of advance preparation. Four facilitating factors of virtual visit use were identified: providing multidimensional professional support; strengthening coordination services; understanding the preferences of patients and their families; and enhancing privacy and security protection. In the quality appraisal of 35 studies, 12 studies were rated as low, five as medium and 18 as high methodological quality.ConclusionThis review identified key facilitating factors and barriers to ICU virtual visits, which can foster the development of infrastructure, virtual visiting workflows, guidelines, policies and visiting systems to improve ICU virtual visiting services. Further studies are necessary to identify potential solutions to the identified barriers.

show abstract

Resource utilization and preparedness within the COVID-19 pandemic in Tunisian medical intensive care units: A nationwide retrospective multicentre observational study

Cited by 7 publications

References 30 publications

Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador

Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador

Laboratory testing efficiency during the COVID pandemic: Findings from the Primary Health Care Corporation laboratories in the State of Qatar

The facilitators and barriers to implementing virtual visits in intensive care units: A mixed‐methods systematic review

Contact Info

Product

Resources

About